Afferent loop syndrome is a known complication of pancreaticoduodenectomy. The incidence may be as high as 13%, and survival of 3 years or longer is the only factor associated with its development.\[[@ref1]\] Surgical, percutaneous, and endoscopic treatments of afferent loop syndrome have been described, but such treatments are not always feasible. Successful treatment through EUS--guided hepaticogastrostomy has also been reported by our group.\[[@ref2]\] We herein present a video case of EUS-guided gastroenterostomy for afferent loop syndrome treatment with SPAXUS® stent (Taewong Medical, Gyeonggi-do, South Korea).

An 80-year-old man, who had undergone Whipple surgery in 2012 for pancreatic adenocarcinoma, was referred for abdominal pain and fever associated with bile duct and afferent loop dilation. A nodule of carcinomatosis localized in the gastrojejunal anastomosis, which was causing the obstruction, was punctured, and carcinoma relapse was histologically confirmed \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\].

![Nodule of carcinomatosis localized in the gastrojejunal anastomosis](EUS-7-418-g001){#F1}

![Nodule of carcinomatosis and dilated afferent loop](EUS-7-418-g002){#F2}

Transgastric puncture of the dilated afferent loop was performed with a 10-Fr Cystotome™ (Cook Medical Ireland, Limrick, Ireland)). Contrast was injected for fluoroscopic viewing of limb and bile duct dilatation \[[Figure 3](#F3){ref-type="fig"}\]. The incision was enlarged with the 10-Fr Cystotome after insertion of a 0.035-inch guidewire (G-FLEX®, Nivelles, Belgium). A 2-cm-long × 16-mm-diameter ASPAXUS® stent (TaeWoong Medical, Gyeonggi-do, South Korea) was deployed under fluoroscopic view. An 8-mm Hurricane dilatation balloon (Boston Scientific Corp, MA, USA) was then used to dilate the tract within the lumen of the NTI-S™ SPAXUS® stent (Taewong Medical, Gyeonggi-do, South Korea), and a 7-cm × 7-Fr pigtail stent was inserted within the stent to prevent migration \[[Figure 4](#F4){ref-type="fig"}\].

![Fluoroscopic view: Limb and bile duct dilatation](EUS-7-418-g003){#F3}

![Fluoroscopic view: 7-cm × 7-Fr pigtail stent within SPAXUS^®^ stent](EUS-7-418-g004){#F4}

No serious complication was reported after the procedure, except for abdominal pain, which was managed with analgesic. The patient was discharged 4 days after the procedure. The patient died 3 months after the procedure because of disease progression.

EUS-guided treatment of afferent loop syndrome has been reported using transgastric plastic stent insertion,\[[@ref3]\] metallic stent (NAGY and AXIOS),\[[@ref4][@ref5]\] and also hepaticogastrostomy,\[[@ref2]\] as we have already mentioned.

To our knowledge, this is the first reported case of treatment with the SPAXUS® stent. EUS-guided gastroenterostomy in this clinical case was performed safely and efficiently, but larger series is needed to evaluate the procedure.
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